About Intellectual Property IP Training Respect for IP IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgments IP Resources IP Reports Patent Protection Trademark Protection Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships AI Tools & Services The Organization Working at WIPO Accountability Patents Trademarks Designs Geographical Indications Copyright Trade Secrets Future of IP WIPO Academy Workshops & Seminars IP Enforcement WIPO ALERT Raising Awareness World IP Day WIPO Magazine Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Youth Examiners Innovation Ecosystems Economics Finance Intangible Assets Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Frontier Technologies Mobile Applications Sports Tourism Music Fashion PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center World Intangible Investment Highlights WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Webcast WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions Build Back Fund National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO Translate Speech-to-Text Classification Assistant Member States Observers Director General Activities by Unit External Offices Staff Positions Affiliated Personnel Positions Procurement Results & Budget Financial Reporting Oversight
Arabic English Spanish French Russian Chinese
Laws Treaties Judgments Browse By Jurisdiction

Boards of Appeal of the European Patent Office [2023]: Case No. T 1779/21 – Fenfluramine for Use in the Treatment of Dravet Syndrome, European Patent Organisation (EPO)

Back This judgment is a part of the following collection(s): 2025 WIPO Intellectual Property Judges Forum Date of Judgment December 19, 2023 Issuing Authority Boards of Appeal: Technical Board of Appeal Level of the Issuing Authority Final Instance Type of Procedure Judicial (Administrative) Subject Matter Patents (Inventions) Plaintiff/Appellant Teva Pharmaceutical Industries Ltd. Defendant/Respondent Katholieke Universiteit Leuven, University Hospital Antwerp Keywords
Sufficiency of disclosure, Pharmaceutical patents
Judgment/Decision English Boards of Appeal of the European Patent Office [2023]: Case No. T 1779/21 – Fenfluramine for Use in the Treatment of Dravet Syndrome  HTML Additional Documents English 2025 WIPO IP Judges Forum Informal Case Summary - Boards of Appeal of the European Patent Office [2023]: Case No. T 1779/21 – Fenfluramine for Use in the Treatment of Dravet Syndrome  HTML Relevant Treaties WIPO Lex No. EPO108-j